Water Street acquired OraPharma from Johnson & Johnson. Our team transformed the business into a standalone company and recruited a highly talented management team spearheaded by CEO Janet Vergis. We leveraged our team’s extensive experience and deep expertise in the pharmaceutical sector to accelerate OraPharma’s growth, improve profitability, and advance attractive new product and market opportunities. Together with management, we built OraPharma into a leading oral health pharmaceutical company. In 2012, Valeant Pharmaceuticals, one of the world’s leading specialty pharmaceutical companies, purchased OraPharma from Water Street.